Ala. ruling may hamper drug innovation in the U.S., critics say

03/17/2013 | Epoch Times, The

Pfizer and other pharmaceutical firms have called on the Alabama Supreme Court to reconsider its ruling to hold brand-name drug companies responsible for physical injuries caused by a generic version of acid reflux drug Reglan. Critics said that the ruling may hamper innovation and decrease the number of newly developed drugs in the country.

View Full Article in:

Epoch Times, The